VRTX logo

VRTX
Vertex Pharmaceuticals, Inc.

12,717
Mkt Cap
$107.83B
Volume
189,153.00
52W High
$507.92
52W Low
$362.50
PE Ratio
27.64
VRTX Fundamentals
Price
$428.07
Prev Close
$423.92
Open
$423.54
50D MA
$453.52
Beta
0.56
Avg. Volume
1.07M
EPS (Annual)
$15.32
P/B
5.77
Rev/Employee
$1.89M
$112,391.78
Loading...
Loading...
News
all
press releases
The Zacks Analyst Blog Highlights Moderna, Merck and Vertex Pharmaceuticals
Moderna jumps despite a Q1 loss as strong international vaccine sales drive revenue surge and boost investor sentiment.
Zacks·8h ago
News Placeholder
More News
News Placeholder
Tyson Foods, Williams Companies And 3 Stocks To Watch Heading Into Monday
Focus on earnings reports from Tyson Foods, Williams Companies, Skycorp Solar, Vertex Pharmaceuticals, and ON Semiconductor.read more...
Benzinga·8h ago
News Placeholder
Best Biotech Stocks To Watch Today - May 3rd
Danaher, Moderna, Vertex Pharmaceuticals, Celcuity, and Oruka Therapeutics are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies focused on developing, manufacturing, or commercializing biological or medical...
MarketBeat·22h ago
News Placeholder
PFA Pension Forsikringsaktieselskab Takes Position in Vertex Pharmaceuticals Incorporated $VRTX
PFA Pension Forsikringsaktieselskab acquired a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F...
MarketBeat·1d ago
News Placeholder
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Oppenheimer Asset Management Inc.
Oppenheimer Asset Management Inc. reduced its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 34.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,720 shares of the ph...
MarketBeat·1d ago
News Placeholder
Best Biotech Stocks To Keep An Eye On - May 2nd
Danaher, Moderna, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop, manufacture, or commercialize biologically based products and technologiessuch as drugs, vaccines...
MarketBeat·2d ago
News Placeholder
3,167 Shares in Vertex Pharmaceuticals Incorporated $VRTX Bought by Sandro Wealth Management LLC
Sandro Wealth Management LLC purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 3,167 share...
MarketBeat·2d ago
News Placeholder
Vertex Pharmaceuticals (NASDAQ:VRTX) Lowered to "Hold" Rating by Wall Street Zen
Wall Street Zen lowered Vertex Pharmaceuticals from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·2d ago
News Placeholder
Biotech Stocks To Follow Today - May 1st
Moderna, Danaher, Lakewood-Amedex Biotherapeutics, Celcuity, and Vertex Pharmaceuticals are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that use biological research and technologies to discover, develop, and commercia...
MarketBeat·3d ago
News Placeholder
Moderna Reports Q1 Loss, Stock Jumps on Strong International Sales
MRNA narrows Q1 loss and beats revenue estimates as international vaccine sales surge, lifting shares despite hefty litigation charges.
Zacks·3d ago
<
1
2
...
>

Latest VRTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.